STRT STRATTEC posts 126 percent Q1 2026 EPS beat stock rises 053 percent on solid year over year revenue growth New EDU Stock Tracking Stock Breakdown Watch 20260420 FMNB Farmers stock climbs 161 percent even as Q4 2025 EPS lands 158 percent below analyst estimates Simon Property Group SPG Evolving Investment Narrative Amid Mixed Analyst Ratings Leadership Transition and Strategic Growth Push Surging Gas Prices Disproportionately Impact LowerIncome Households New York Fed Study Reveals Bread BFH Reports Strong Q1 2026 Revenue NA EPS Beats Auddia AUUD Surges 6434 Nearing 210 Resistance 20260515 Citi Raises CocaCola Price Target to 91 on World Cup Catalyst Maintains Buy Rating ProfitTaking Strategy CNBC Analyst Trims Position After 80 Rally Since April Tax Season 2025 New Rules for Online Sellers and EV Buyers Could Boost Refunds Meta Shares Slide After Quarterly Report Iran Internet Disruptions Weigh on User Metrics Microsofts GitHub was positioned to win the AI coding race Outages got in the way Telecoms CEO Warns of US Dominance in Satellites and AI Highlighting Europes Connectivity Vulnerabilities Samir Arora Dismisses SIPs as Cause of Rupee Weakness Highlights Domestic Support Expion360 Q2 2025 Earnings EPS Beats Estimates by 307 Amid Cost Discipline Purple Innovation PRPL Q1 2026 Earnings Small EPS Beat Fails to Lift Shares Amid Revenue Disclosures ENLT Q1 2026 Earnings Positive EPS Surprise Drives Modest Stock Gain ALGM Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Gain OMER Q1 2026 Earnings EPS Beats Estimates as Operating Expenses Decline But Stock Falls on Lack of Revenue Spire Inc SR Q1 2026 Earnings EPS Beats Estimates on Solid Operations NSTS Bancorp Inc NSTS Holds Steady at 1377 as Traders Eye Support and Resistance Levels Zura Bio Limited ZURA Climbs 238 Testing Resistance at 453 Gartner IT Climbs 1 as Stock Holds Above Support Tests Resistance Bayview Acquisition Corp BAYA Plunges 565 as SPAC Premium Shrinks Amid Deal Uncertainty PagerDuty PD Breaks Above Recent Range After 348 Surge XPO Inc XPO Posts Modest Gains as Logistics Demand Holds Steady Myriad Genetics MYGN Slips as Stock Navigates Support Levels Near 359 Evergy EVRG Slips 157 as Utility Sector Faces Headwinds Key Levels in Focus BHFAO Preferred Shares Hold Steady at 1601 Amid Narrow Trading Range Utah Medical Products Edges Lower as Stock Holds Between Key Support and Resistance Levels Castle Biosciences Slides 208 as Shares Test Support Near 1973 Mercks Phase 3 TroFuse005 Trial for Endometrial Cancer Meets Dual Primary Endpoints NGL Q1 2026 Earnings EPS Misses Estimates Stock Declines Autonomix Medical AMIX Shows Subtle Weakness at 042 as Support and Resistance Tighten